_version_ 1784784960828211200
author Gurnari, Carmelo
Piciocchi, Alfonso
Soddu, Stefano
Bonanni, Fabrizio
Scalzulli, Emilia
Niscola, Pasquale
Di Veroli, Ambra
Piccioni, Anna Lina
Piedimonte, Monica
Maiorana, Gianluca
Salutari, Prassede
Cicconi, Laura
Santopietro, Michelina
Gumenyuk, Svitlana
Sarlo, Chiara
Fenu, Susanna
Tafuri, Agostino
Latagliata, Roberto
Fianchi, Luana
Criscuolo, Marianna
Maciejewski, Jaroslaw P.
Maurillo, Luca
Buccisano, Francesco
Breccia, Massimo
Voso, Maria Teresa
author_facet Gurnari, Carmelo
Piciocchi, Alfonso
Soddu, Stefano
Bonanni, Fabrizio
Scalzulli, Emilia
Niscola, Pasquale
Di Veroli, Ambra
Piccioni, Anna Lina
Piedimonte, Monica
Maiorana, Gianluca
Salutari, Prassede
Cicconi, Laura
Santopietro, Michelina
Gumenyuk, Svitlana
Sarlo, Chiara
Fenu, Susanna
Tafuri, Agostino
Latagliata, Roberto
Fianchi, Luana
Criscuolo, Marianna
Maciejewski, Jaroslaw P.
Maurillo, Luca
Buccisano, Francesco
Breccia, Massimo
Voso, Maria Teresa
author_sort Gurnari, Carmelo
collection PubMed
description
format Online
Article
Text
id pubmed-9452671
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-94526712022-09-09 Myelodysplastic syndromes with del(5q): A real-life study of determinants of long-term outcomes and response to lenalidomide Gurnari, Carmelo Piciocchi, Alfonso Soddu, Stefano Bonanni, Fabrizio Scalzulli, Emilia Niscola, Pasquale Di Veroli, Ambra Piccioni, Anna Lina Piedimonte, Monica Maiorana, Gianluca Salutari, Prassede Cicconi, Laura Santopietro, Michelina Gumenyuk, Svitlana Sarlo, Chiara Fenu, Susanna Tafuri, Agostino Latagliata, Roberto Fianchi, Luana Criscuolo, Marianna Maciejewski, Jaroslaw P. Maurillo, Luca Buccisano, Francesco Breccia, Massimo Voso, Maria Teresa Blood Cancer J Correspondence Nature Publishing Group UK 2022-09-07 /pmc/articles/PMC9452671/ /pubmed/36071048 http://dx.doi.org/10.1038/s41408-022-00724-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correspondence
Gurnari, Carmelo
Piciocchi, Alfonso
Soddu, Stefano
Bonanni, Fabrizio
Scalzulli, Emilia
Niscola, Pasquale
Di Veroli, Ambra
Piccioni, Anna Lina
Piedimonte, Monica
Maiorana, Gianluca
Salutari, Prassede
Cicconi, Laura
Santopietro, Michelina
Gumenyuk, Svitlana
Sarlo, Chiara
Fenu, Susanna
Tafuri, Agostino
Latagliata, Roberto
Fianchi, Luana
Criscuolo, Marianna
Maciejewski, Jaroslaw P.
Maurillo, Luca
Buccisano, Francesco
Breccia, Massimo
Voso, Maria Teresa
Myelodysplastic syndromes with del(5q): A real-life study of determinants of long-term outcomes and response to lenalidomide
title Myelodysplastic syndromes with del(5q): A real-life study of determinants of long-term outcomes and response to lenalidomide
title_full Myelodysplastic syndromes with del(5q): A real-life study of determinants of long-term outcomes and response to lenalidomide
title_fullStr Myelodysplastic syndromes with del(5q): A real-life study of determinants of long-term outcomes and response to lenalidomide
title_full_unstemmed Myelodysplastic syndromes with del(5q): A real-life study of determinants of long-term outcomes and response to lenalidomide
title_short Myelodysplastic syndromes with del(5q): A real-life study of determinants of long-term outcomes and response to lenalidomide
title_sort myelodysplastic syndromes with del(5q): a real-life study of determinants of long-term outcomes and response to lenalidomide
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452671/
https://www.ncbi.nlm.nih.gov/pubmed/36071048
http://dx.doi.org/10.1038/s41408-022-00724-3
work_keys_str_mv AT gurnaricarmelo myelodysplasticsyndromeswithdel5qareallifestudyofdeterminantsoflongtermoutcomesandresponsetolenalidomide
AT piciocchialfonso myelodysplasticsyndromeswithdel5qareallifestudyofdeterminantsoflongtermoutcomesandresponsetolenalidomide
AT soddustefano myelodysplasticsyndromeswithdel5qareallifestudyofdeterminantsoflongtermoutcomesandresponsetolenalidomide
AT bonannifabrizio myelodysplasticsyndromeswithdel5qareallifestudyofdeterminantsoflongtermoutcomesandresponsetolenalidomide
AT scalzulliemilia myelodysplasticsyndromeswithdel5qareallifestudyofdeterminantsoflongtermoutcomesandresponsetolenalidomide
AT niscolapasquale myelodysplasticsyndromeswithdel5qareallifestudyofdeterminantsoflongtermoutcomesandresponsetolenalidomide
AT diveroliambra myelodysplasticsyndromeswithdel5qareallifestudyofdeterminantsoflongtermoutcomesandresponsetolenalidomide
AT piccioniannalina myelodysplasticsyndromeswithdel5qareallifestudyofdeterminantsoflongtermoutcomesandresponsetolenalidomide
AT piedimontemonica myelodysplasticsyndromeswithdel5qareallifestudyofdeterminantsoflongtermoutcomesandresponsetolenalidomide
AT maioranagianluca myelodysplasticsyndromeswithdel5qareallifestudyofdeterminantsoflongtermoutcomesandresponsetolenalidomide
AT salutariprassede myelodysplasticsyndromeswithdel5qareallifestudyofdeterminantsoflongtermoutcomesandresponsetolenalidomide
AT cicconilaura myelodysplasticsyndromeswithdel5qareallifestudyofdeterminantsoflongtermoutcomesandresponsetolenalidomide
AT santopietromichelina myelodysplasticsyndromeswithdel5qareallifestudyofdeterminantsoflongtermoutcomesandresponsetolenalidomide
AT gumenyuksvitlana myelodysplasticsyndromeswithdel5qareallifestudyofdeterminantsoflongtermoutcomesandresponsetolenalidomide
AT sarlochiara myelodysplasticsyndromeswithdel5qareallifestudyofdeterminantsoflongtermoutcomesandresponsetolenalidomide
AT fenususanna myelodysplasticsyndromeswithdel5qareallifestudyofdeterminantsoflongtermoutcomesandresponsetolenalidomide
AT tafuriagostino myelodysplasticsyndromeswithdel5qareallifestudyofdeterminantsoflongtermoutcomesandresponsetolenalidomide
AT latagliataroberto myelodysplasticsyndromeswithdel5qareallifestudyofdeterminantsoflongtermoutcomesandresponsetolenalidomide
AT fianchiluana myelodysplasticsyndromeswithdel5qareallifestudyofdeterminantsoflongtermoutcomesandresponsetolenalidomide
AT criscuolomarianna myelodysplasticsyndromeswithdel5qareallifestudyofdeterminantsoflongtermoutcomesandresponsetolenalidomide
AT maciejewskijaroslawp myelodysplasticsyndromeswithdel5qareallifestudyofdeterminantsoflongtermoutcomesandresponsetolenalidomide
AT maurilloluca myelodysplasticsyndromeswithdel5qareallifestudyofdeterminantsoflongtermoutcomesandresponsetolenalidomide
AT buccisanofrancesco myelodysplasticsyndromeswithdel5qareallifestudyofdeterminantsoflongtermoutcomesandresponsetolenalidomide
AT brecciamassimo myelodysplasticsyndromeswithdel5qareallifestudyofdeterminantsoflongtermoutcomesandresponsetolenalidomide
AT vosomariateresa myelodysplasticsyndromeswithdel5qareallifestudyofdeterminantsoflongtermoutcomesandresponsetolenalidomide